23andMe Bankruptcy Sale

Order byBest matchMost fresh

23andMe, DNA

Timeline: 23andMe’s Journey From DNA Testing Pioneer to Bankruptcy Sale

Drugmaker Regeneron Pharmaceuticals is acquiring majority assets of bankrupt genetic testing firm 23andMe Holding for $256 million.

· 2d

· 2d · on MSN

Regeneron Pharmaceuticals to pay $256 million for 23andMe in bankruptcy sale

· 1d · on MSN

23andMe To Be Sold in Bankruptcy: What It Means for Your DNA Data

23andMe Sold To Biotechnology Company For $256 Million

Regeneron will be keeping all of 23andMe’s employees, Jensen added.

· 2d

Putnam Daily Voice · 1d

Westchester-Based Regeneron Buying Bankrupt 23andMe For $256M, Pledges To Protect DNA Data

· 1d

Genetic Data From 23andMe Ends Up With This Company In $256 Million Deal

23andMe to Be Bought by Biotech Company for $256 Million

Regeneron Pharmaceuticals said it would acquire 23andMe, which filed for bankruptcy in March and would continue to offer consumer DNA testing services.

1don MSN

23andMe Found a Buyer for Our Genetic Data, and I’m Kind of Optimistic

Before, we told you to delete your data because 23andMe was about to be sold. Now, a buyer has been announced, and they’re promising to “prioritize the privacy, security and ethical use” of customer data,